Novartis helps fund significant UK research project

A major public-private research initiative in the UK,  Our Future Health, has added a new partner from industry, Swiss pharma giant Novartis (NOVN: VX).

Launched in 2022, the research project has secured the participation of millions of British people, who are submitting health data including from a finger-prick blood test.

The goal is to enable large-scale research into major health conditions, with the country’s National Health Service (NHS) set to benefit from an improved understanding of the impact of treatments on public health.